Post-COVID central hypersomnia, a treatable trait in long COVID: 4 case reports

IntroductionFatigue is the most commonly reported post-COVID symptom. A minority of patients also report excessive daytime sleepiness, which could be a target for treatment.MethodsAmong 530 patients with a post-COVID condition, those with excessive daytime sleepiness were systematically assessed for...

Full description

Bibliographic Details
Main Authors: Clémence Morelli-Zaher, Andrea Vremaroiu-Coman, Nicolas Coquoz, Léon Genecand, Marco Altarelli, Alzbeta Binkova, Isabelle Frésard, Pierre-Olivier Bridevaux, Grégoire Gex
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2024.1349486/full
_version_ 1827351414676914176
author Clémence Morelli-Zaher
Andrea Vremaroiu-Coman
Nicolas Coquoz
Léon Genecand
Marco Altarelli
Alzbeta Binkova
Isabelle Frésard
Pierre-Olivier Bridevaux
Pierre-Olivier Bridevaux
Pierre-Olivier Bridevaux
Grégoire Gex
Grégoire Gex
Grégoire Gex
author_facet Clémence Morelli-Zaher
Andrea Vremaroiu-Coman
Nicolas Coquoz
Léon Genecand
Marco Altarelli
Alzbeta Binkova
Isabelle Frésard
Pierre-Olivier Bridevaux
Pierre-Olivier Bridevaux
Pierre-Olivier Bridevaux
Grégoire Gex
Grégoire Gex
Grégoire Gex
author_sort Clémence Morelli-Zaher
collection DOAJ
description IntroductionFatigue is the most commonly reported post-COVID symptom. A minority of patients also report excessive daytime sleepiness, which could be a target for treatment.MethodsAmong 530 patients with a post-COVID condition, those with excessive daytime sleepiness were systematically assessed for objective central hypersomnia, with exclusion of all cases not clearly attributable to SARS-CoV-2 infection.ResultsFour cases of post-COVID central hypersomnia were identified, three fulfilling the criteria of the 3rd International Classification of Sleep Disorders for idiopathic hypersomnia, and one for type II narcolepsy. We report here their clinical history, sleep examination data and treatment, with a favorable response to methylphenidate in three cases and spontaneous resolution in one case.ConclusionWe highlight the importance of identifying cases of post-COVID central hypersomnia, as it may be a treatable trait of a post-COVID condition.
first_indexed 2024-03-08T02:02:54Z
format Article
id doaj.art-99a955bcc1a04fb884b699ff4454e2ca
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-03-08T02:02:54Z
publishDate 2024-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-99a955bcc1a04fb884b699ff4454e2ca2024-02-14T05:00:48ZengFrontiers Media S.A.Frontiers in Neurology1664-22952024-02-011510.3389/fneur.2024.13494861349486Post-COVID central hypersomnia, a treatable trait in long COVID: 4 case reportsClémence Morelli-Zaher0Andrea Vremaroiu-Coman1Nicolas Coquoz2Léon Genecand3Marco Altarelli4Alzbeta Binkova5Isabelle Frésard6Pierre-Olivier Bridevaux7Pierre-Olivier Bridevaux8Pierre-Olivier Bridevaux9Grégoire Gex10Grégoire Gex11Grégoire Gex12Division of Pulmonology, Centre Hospitalier du Valais Romand, Hôpital du Valais, Sion, SwitzerlandDivision of Pulmonology, Centre Hospitalier du Valais Romand, Hôpital du Valais, Sion, SwitzerlandDivision of Pulmonology, Centre Hospitalier du Valais Romand, Hôpital du Valais, Sion, SwitzerlandDivision of Pulmonology, Centre Hospitalier du Valais Romand, Hôpital du Valais, Sion, SwitzerlandDivision of Pulmonology, Centre Hospitalier du Valais Romand, Hôpital du Valais, Sion, SwitzerlandDivision of Pulmonology, Centre Hospitalier du Valais Romand, Hôpital du Valais, Sion, SwitzerlandDivision of Pulmonology, Centre Hospitalier du Valais Romand, Hôpital du Valais, Sion, SwitzerlandDivision of Pulmonology, Centre Hospitalier du Valais Romand, Hôpital du Valais, Sion, SwitzerlandDivision of Pulmonology, Geneva University Hospitals, Geneva, SwitzerlandFaculty of Medicine, University of Geneva, Geneva, SwitzerlandDivision of Pulmonology, Centre Hospitalier du Valais Romand, Hôpital du Valais, Sion, SwitzerlandDivision of Pulmonology, Geneva University Hospitals, Geneva, SwitzerlandFaculty of Medicine, University of Geneva, Geneva, SwitzerlandIntroductionFatigue is the most commonly reported post-COVID symptom. A minority of patients also report excessive daytime sleepiness, which could be a target for treatment.MethodsAmong 530 patients with a post-COVID condition, those with excessive daytime sleepiness were systematically assessed for objective central hypersomnia, with exclusion of all cases not clearly attributable to SARS-CoV-2 infection.ResultsFour cases of post-COVID central hypersomnia were identified, three fulfilling the criteria of the 3rd International Classification of Sleep Disorders for idiopathic hypersomnia, and one for type II narcolepsy. We report here their clinical history, sleep examination data and treatment, with a favorable response to methylphenidate in three cases and spontaneous resolution in one case.ConclusionWe highlight the importance of identifying cases of post-COVID central hypersomnia, as it may be a treatable trait of a post-COVID condition.https://www.frontiersin.org/articles/10.3389/fneur.2024.1349486/fullidiopathic hypersomniacentral hypersomnianarcolepsylong COVIDpost-COVID conditiontreatment
spellingShingle Clémence Morelli-Zaher
Andrea Vremaroiu-Coman
Nicolas Coquoz
Léon Genecand
Marco Altarelli
Alzbeta Binkova
Isabelle Frésard
Pierre-Olivier Bridevaux
Pierre-Olivier Bridevaux
Pierre-Olivier Bridevaux
Grégoire Gex
Grégoire Gex
Grégoire Gex
Post-COVID central hypersomnia, a treatable trait in long COVID: 4 case reports
Frontiers in Neurology
idiopathic hypersomnia
central hypersomnia
narcolepsy
long COVID
post-COVID condition
treatment
title Post-COVID central hypersomnia, a treatable trait in long COVID: 4 case reports
title_full Post-COVID central hypersomnia, a treatable trait in long COVID: 4 case reports
title_fullStr Post-COVID central hypersomnia, a treatable trait in long COVID: 4 case reports
title_full_unstemmed Post-COVID central hypersomnia, a treatable trait in long COVID: 4 case reports
title_short Post-COVID central hypersomnia, a treatable trait in long COVID: 4 case reports
title_sort post covid central hypersomnia a treatable trait in long covid 4 case reports
topic idiopathic hypersomnia
central hypersomnia
narcolepsy
long COVID
post-COVID condition
treatment
url https://www.frontiersin.org/articles/10.3389/fneur.2024.1349486/full
work_keys_str_mv AT clemencemorellizaher postcovidcentralhypersomniaatreatabletraitinlongcovid4casereports
AT andreavremaroiucoman postcovidcentralhypersomniaatreatabletraitinlongcovid4casereports
AT nicolascoquoz postcovidcentralhypersomniaatreatabletraitinlongcovid4casereports
AT leongenecand postcovidcentralhypersomniaatreatabletraitinlongcovid4casereports
AT marcoaltarelli postcovidcentralhypersomniaatreatabletraitinlongcovid4casereports
AT alzbetabinkova postcovidcentralhypersomniaatreatabletraitinlongcovid4casereports
AT isabellefresard postcovidcentralhypersomniaatreatabletraitinlongcovid4casereports
AT pierreolivierbridevaux postcovidcentralhypersomniaatreatabletraitinlongcovid4casereports
AT pierreolivierbridevaux postcovidcentralhypersomniaatreatabletraitinlongcovid4casereports
AT pierreolivierbridevaux postcovidcentralhypersomniaatreatabletraitinlongcovid4casereports
AT gregoiregex postcovidcentralhypersomniaatreatabletraitinlongcovid4casereports
AT gregoiregex postcovidcentralhypersomniaatreatabletraitinlongcovid4casereports
AT gregoiregex postcovidcentralhypersomniaatreatabletraitinlongcovid4casereports